AndhraNews.net
Home » Features » Health » Bird Flu

Bird Flu


Why bird flu didn't become a pandemic
A new study has revealed that why irrespective of the 2005 outbreak of the H5N1 bird flu virus in South East Asia, it didnt turn into a pandemic. ANI

Dead pigeons, boa constrictor among top weird finds at UK airports
Dead pigeons, pet boa constrictor-these are some of the animals people have tried to smuggle into the UK, according to reports. he UK Border Agency (UKBA) has published a list of its strangest finds following the discovery of the birds at Gatwick Airport last month. ANI

Frost & Sullivan: Medical Waste Finds Growth in Malaysia's Robust Healthcare System
PR Newswire

eLong Reports Second Quarter 2010 Unaudited Financial Results
PR Newswire

How virus jumps from host to host
A new study has found how viruses jump from host to host. ANI

Now, a universal vaccine that could fend off all types of flu
A universal flu vaccine could be the one fits all jab - a new two-step approach to immunisation. ANI

Novel inhaled drug found effective against H5N1 avian influenza virus
Researchers have found a novel compound highly effective against the pathogenic H5N1 avian influenza virus, including some drug-resistant strains. ANI

Jharkhnad issues alert as bird flu hits bordering West Bengal
In the wake of the outbreak of avian influenza in bordering West Bengal, the Jharkhand Animal Husbandry Department is taking preventive measures against the flu in bordering villages as issued an alert. ANI

New method for a cheaper version of anti-flu drug Tamiflu developed
Paving way for a less expensive version of Tamiflu, scientists have developed an alternative method for producing the active ingredient in the drug that fights the dreadful H1N1 and other forms of influenza.The new process could expand availability of the drug by reducing its cost, which now retails for as about 8 dollars per dose. ANI

Experimental compound found effective against deadly bird flu
An experimental compound might prove to be a potent weapon against drug-resistant form of the deadly H5N1 avian influenza also known as bird flu, say researchers. ANI

Experimental compound found effective against deadly bird flu
An experimental compound might prove to be a potent weapon against drug-resistant form of the deadly H5N1 avian influenza also known as bird flu, say researchers. ANI

Why bird flu has not become a pandemic
A new study by American and British scientists has tried to explain why bird flu has not become a pandemic disease. ANI

Poultry farmers in Punjab lament J and K Govts high import duties
Poultry farming in Punjab, which suffered heavy losses and closures during terrorism days and recently following the Bird flu scare, is now faced with another problem in the form of heavy tax duties. ANI

Lies, half truths and media hype of swine flu (Article)
I wonder as to how long will medicines flagship educational events (like warning of epidemics) fly the colours of the drug industry. Isnt this a new Avatar of the common influenza that we have had for centuries? ANI

H1N1 flu virus has mutated into a form resistant to an antiviral drug
Scientists have found that some mutation has made the H1N1 flu virus resistant to the Australian-developed antiviral drug Relenza. ANI

British aristocrats corpse may hold swine flu key
Scientists believe the corpse of a British aristocrat who died 90 years ago could provide vital information about the swine flu epidemic. ANI

Deadly flu viruses lurk in humans, animals for years before pandemic outbreaks
A new piece of research suggests that components of deadly flu viruses probably lurk in humans and other animals for years before they emerge as a worldwide threat to human health. ANI

Shanghai firm rolls out antiviral drug to combat swine flu
A pharmaceutical company in Shanghai has rolled out the first batch of antiviral drugs to combat Influenza A (H1N1) virus, which is responsible for the swine flu pandemic around the world. ANI

New interferon response could offer early control of bird flu virus
The cell-signalling protein, interferon type 1, has the potential to reduce H5N1 influenza virus (bird flu virus) replication in mice, and can thus offer protection in the early stages of infection, according to researchers from Georgia. ANI

Purifier device that can wipe out swine, bird flu developed
British scientists have developed a revolutionary machine which can wipe out swine and bird flu, it has been revealed. ANI

Bird flu virus can survive in buried birds carcasses for 2yrs
Bird flu virus can survive for up to two years in the carcasses of buried birds, according to a new study. ANI

Host species extinction could make parasites jump onto alternative hosts
In a new study, scientists have determined that when host species go extinct, their parasites could switch onto alternative hosts which in turn could increase the rate of emerging pathogens for humans, domesticated animals and plants. ANI

Human nose too cold for bird flu viruses to thrive
A study authored by researchers at from Imperial College London and the University of North Carolina has revealed that avian influenza viruses do not thrive in humans because the temperature inside their noses is very low. ANI

Human nose too cold for bird flu viruses to thrive
A study authored by researchers at from Imperial College London and the University of North Carolina has revealed that avian influenza viruses do not thrive in humans because the temperature inside their noses is very low. ANI

Katy Perrys trendy swine flu-inspired ring!
Katy Perry has vowed to be in style with her flying pig ring just as the world tries to tackle a global pandemic. ANI

Swine flus first genetic analysis reveals potency
While swine flu virus H1N1 continues to spread around the world, the first genetic analysis of the efficacy of its transmission from person to person revealed that it spreads barely well enough to keep itself going. ANI

Surveillance and personal hygiene key to ward off swine flu
Doctors representing various professional organisations and systems of medicine on Friday spelt out the preparedness to deal with the outbreak of the H1N1 virus, commonly known as swine flu, here. ANI

What you need to know about swine flu
While there have been a number of outbreaks of the new strain of swine flu, there also have emerged a whole gamut of misinformation. Now, scientists have elaborated exactly what one needs to know about this new epidemic. ANI

New study warns over pandemic flu vaccine 6-month time lag
It will take at least six months to come up with an effective vaccine in the event of a pandemic flu outbreak, scientists have warned.Dr Iain Stephenson, Consultant in Infectious Diseases at the Leicester Royal Infirmary and a Clinical Senior Lecturer at the University of Leicester, said that by that time, the first wave of pandemic flu might be over before people are vaccinated. ANI

West Bengal reports fresh bird flu outbreak
A month after authorities claimed that it was contained, bird flu has resurfaced in West Bengals Darjeeling district. ANI

New discovery to make human vaccine against bird flu a reality
Researchers at University of Melbourne claim that they are closer to developing a human vaccine for avian influenza, commonly known as bird flu, after making a new discovery. ANI

West Bengal authorities gear up to contain bird flu
Health authorities in West Bengal today said they are working in tandem with civic authorities to spread awareness about clean husbandry practices to counter bird flu. ANI

Culling of birds completed in Nepal
The Rapid Response Teams (RRT) deployed to control bird flu in Sharanmati area Jhapa district has completed its culling operation on Wednesday. ANI

West Bengal to begin culling after reports of bird flu in Siliguri
Authorities in West Bengal have said about 5,000 birds would be culled after Siliguri reported cases of H5N1 strain of bird flu virus. ANI

Culling of birds begin in Nepal
Nepal Government has started culling of poultry and poultry products in the bird flu affected of area of Sharanamati in Jhapa district. ANI

Vaccine targeting Achilles heel in all flu viruses comes closer to reality
A potential new flu vaccine to cure almost all kinds of the disease, including bird flue, may be available in just two years because scientists have identified 10 antibodies that target an Achilles heel in most forms of influenza. ANI

Bird flu strikes Nepal
Though the Nepal Government has announced that bird flu in the countrys Kakarbhitta area is under control, avian virus has surfaced again in Sharanamati of Jhapa district. ANI

Jaguar conservation can prevent human diseases: Experts
Doctor conservationists say that theres a need to save Jaguars and other big cats from hunters because these animals can protect humans from the rise of future pandemics akin to HIV and bird flu. ANI

Culling of birds continues in West Bengals Coochbehar district
Culling operations are continuing in two bird flu affected villages in West Bengals Coochbehar district. ANI

Bird Flu in News

Nu-Med Plus Draws Global Attention as MERS, SARS and Bird Flu Threats Continue to Increase
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced it has drawn worldwide attention with the increased threats to national economies coming from the spread of MERS, SARS and the Bird Flu.

Sierra Leone Pilot Study of 10 Minute Ebola Rapid Test Shows Promise
Medical diagnostic manufacturer JAJ International, Inc. (www.jajinternational.com) a subsidiary of LuSys Laboratories, Inc., receives promising results from a Sierra Leone Pilot Study for their Point of Care 10 Minute Ebola Rapid Test Diagnostic.

Global Animal Feed Additives (Swine, Poultry, Cattle, Aquaculture, Others)-Forecasts to 2018
Research and Markets (http://www.researchandmarkets.com/research/sg24lv/animal_feed) has announced the addition of the "Global Animal Feed Additives (Swine, Poultry, Cattle, Aquaculture, Others) - Forecasts to 2018" report to their offering.

AirWare Labs Announces Manufacturing and Sales Expansion Into China
AirWare Labs Corp. (OTCQB: AIRW) today announced plans to expand manufacturing, distribution and sales of its AIR® filtered nasal products in China

International SOS and Control Risks Introduce TravelWatch-India
Companies operating in – or with significant business travel within – India can now access accurate and timely information on travel security issues and trends to protect their people, assets and operations

AHF: Obama’s Trade Enforcement against India Threatens Lives, Goal of ‘AIDS Free Generation’
The long-running trade dispute between the US and India over intellectual property (IP) rights could leave millions of people without access to life-saving medications and cripple programs like the President’s Emergency Plan for AIDS Relief (PEPFAR), the respected global AIDS treatment program.

Recap of NanoViricides, Inc. CEO Dr. Eugene Seymour Clear Channel Business Talk Radio Interview
NanoViricides, Inc. (NYSE MKT: NNVC) is a development stage company that is creating special purpose nanomaterials to destroy viruses in and on the body. The Company today announced that Michael Yorba of Clear Channel's Business Talk Radio Show, The Traders Network, interviewed CEO Dr. Eugene Seymour live on December 19, 2013.

NanoViricides CEO Dr. Eugene Seymour to Be Interviewed on Clear Channel DFW 1190AM
NanoViricides, Inc. (NYSE MKT: NNVC) is a development stage company that is creating special purpose nanomaterials to destroy viruses in and on the body. The Company announced today that CEO Dr. Eugene Seymour will be interviewed live by Michal Yorba on Clear Channel Business Talk Radio's Traders Financial Network, Thursday, December 19th, 2013, at 2:00pm CST / 12:00pm PST / 3:00pm EST.

Press Ventures and Biosafety Systems Inc. Announce CLO-D for Testing With Environmental Protection Agency in the U.S.
Press Ventures Inc. (OTCQB: PVEN) ("Press Ventures" or the "Company"), is pleased to announce that the Company, through its wholly-owned subsidiary Biosafety Systems, Inc

A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing
Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their H1N1 influenza vaccine candidate based on Cytos' proprietary bacteriophage Qbeta virus-like particle (VLP) technology

Bird Flu Cases Rise to Nearly 100 as Death Toll Mounts; Majority of Cases Are Hospitalized and Not Recovering
AvianFluTalk.com, created in 2005 as the first ever website and online discussion forum to track the threat of an avian flu pandemic, has announced that the bird flu outbreak in China is far from being controlled.

Spike in Bird Flu Cases Could Indicate Pandemic Is Imminent; Bird Flu Now Spreading Throughout China
AvianFluTalk.com, an online discussion forum created in 2005 to bring awareness of the threat of an avian flu pandemic, has announced that the new H7N9 bird flu virus is spreading in China and could be the next pandemic.

A*STAR Scientist Alex Matter Awarded Prestigious Szent-Gyorgyi Prize For Progress In Cancer Research
Professor Alex Matter, Chief Executive Officer of A*STAR's Experimental Therapeutics Centre (ETC), has been awarded the 8th Annual Szent-Gyorgyi Prize for Progress in Cancer Research by the National Foundation for Cancer Research (NFCR) for his contributions to the development of the first drug specifically targeting a molecular lesion in cancer

Increased Focus on Animal Feed Quality With Rising Meat Consumption
MarketResearch.com has announced the addition of the new report "Global Animal Feed Additives by Types, Livestock & Geography - Trends & Forecasts up to 2017," to their collection of Agriculture market reports.

Cosi, Inc. Receives Nasdaq Notice of Minimum Bid Price
Così, Inc. (NASDAQ: COSI), the fast-casual restaurant company, today announced that it had received notice from the Listing Qualifications Department of the Nasdaq Stock Market indicating that, for the last 30 consecutive business days, the bid price for the Company's common stock had closed below the minimum $1

Cosi Names Hearthstone Associates as Franchisee of the Year
Così, Inc. (NASDAQ: COSI), the fast casual restaurant company, today announced that it had recently honored its Boston area franchisee, Hearthstone Associates, and its President, RJ Dourney, as its "Franchisee of the Year."

Made-in-Singapore H5N1 Bird Flu Diagnostic Kit - Detects All Known Strains of H5N1 Virus with a Single Test
The close collaboration between scientists from the Experimental Therapeutics Centre (ETC) under the Agency for Science and Technology Research (A*STAR) and clinicians from Tan Tock Seng Hospital (TTSH) has enabled the successful development of the most comprehensive and rapid H5N1 bird flu test kit available to date

Cosi, Inc. Reports 2012 First Quarter Results
Così, Inc. (NASDAQ: COSI), the fast casual restaurant company, today reported that it had reduced its net loss for the first quarter ended April 2, 2012 by $1,012,000 or 47% to $(1,128,000), or $(0.02) per basic and diluted common share, compared with the net loss of $(2,140,000), or $(0.04) per basic and diluted common share, reported for the 2011 first quarter.

Rabobank: Thailand bites into Brazilian chicken exports as EU lifts import ban
Utrecht, May 14 2012 - Thailand looks set to return to a leading position in the global poultry market after the EU announced that it will end restrictions on imports of raw poultry meat from Thailand on 1 July 2012. The end of the ban could cut prices for consumers at a time when they have been hard hit by inflation in other foodstuffs

Cosi, Inc. Announces Record Date and Subscription Price for Planned Rights Offering
As previously announced, Così, Inc. (NASDAQ: COSI), the fast casual restaurant company, intends to pursue a rights offering for up to $15 million of its common stock, par value $0.01 per share. A record date of May 24, 2012 has been set for the planned rights offering. In addition, the Company announced that the subscription price for the rights offering will be $0.65 per share.

Cosi, Inc. Announces Planned Rights Offering
Così, Inc. (NASDAQ: COSI), the fast casual restaurant company, today announced that it filed a registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") for a rights offering to its existing shareholders

Cosi Signs New Franchisee for Costa Rica
Così, Inc. (NASDAQ: COSI), the fast casual restaurant company, today announced that it has entered into a development agreement with a new franchisee, Fast Casual S. A., to develop Così® restaurants in Costa Rica. The agreement calls for Fast Casual S.A. to develop five locations over five years beginning with their first location expected to open later this year.

Cosi, Inc. Reports 2011 Fourth Quarter and Full Year Results
Così, Inc. (NASDAQ: COSI), the fast casual restaurant company, today reported a net loss for the fourth quarter ended January 2, 2012 of $(2,274,000), or $(0.04) per basic and diluted common share, compared with a net loss of $(2,784,000), or $(0.05) per basic and diluted common share in the fourth quarter of 2010.

Cosi to Open New Restaurant in Hackensack, New Jersey
Così, Inc. (NASDAQ: COSI), the fast casual restaurant company, today announced that its franchisee, CRM Partners Inc., has entered into a lease to open a Così restaurant in Hackensack, New Jersey. The restaurant which is expected to open in May will be the fourth Così location in New Jersey for CRM Partners

Viroblock Strengthens its Board of Directors and Extends its Series C Funding to CHF 4 Million
Viroblock S.A., the Swiss based anti-viral company, has announced that Mr. David Frederick, Dr. Winfried Mayer and Dr. Erich Platzer have joined Dr. Peter Pfister and Mr. Gian-Luigi Berini on its Board of Directors.

Cosi, Inc. Regains Compliance With Nasdaq Listing Standards
Così, Inc. (NASDAQ: COSI), the fast casual restaurant company, today announced that it has received notice from the Listing Qualifications Department of The Nasdaq Stock Market that the Company has regained compliance with the Nasdaq Listing Standards by curing the Company's bid price and Market Value of Listed Securities deficiencies

China confirms H5N1 bird flu outbreak in Xinjiang
China's northwestern Xinjiang Uygur autonomous region has reported an outbreak of H5N1 in poultry, the Ministry of Agriculture (MOA) announced Monday.

Just 3 more mutations in humans can make bird flu a pandemic
A new research has suggested that it might be possible for human-to-human airborne transmissible avian H5N1 influenza viruses to evolve in nature.

H1N1 discovery could lead to development of universal flu vaccines
Researchers at the University of British Columbia have found a potential way to develop universal flu vaccines and eliminate the need for seasonal flu vaccinations.

Controversial avian flu paper that raised bioterrorism fears finally goes to press
After an epic debate over a pair of studies that reveal how the avian H5N1 influenza virus could become transmissible in mammals, and an unprecedented recommendation by a government review panel to block publication, one of the studies was finally and fully published on Thursday.

Controversial bird flu studies cleared for publication
A US biosecurity committee has withdrawn its objection to the publication of two controversial bird flu studies.

Deadly bird flu studies to be kept secret for now over fear of bioterrorism risks
World Health Organization (WHO) has announced that two studies showing how scientists mutated the H5N1 bird flu virus into a form that could cause a deadly human pandemic will be published only after experts fully assess the risks.

UK study warns of 'extreme' flu pandemic due to Olympics related tourist inflow
A study has warned that the presence of an additional 5.3 million tourists in Britain during the London Olympics will increase the risk of a flu pandemic.

US tells scientists to censor new bird flu research
The United States Government has reportedly asked Dutch scientists to censor key parts of their work that described how they managed to mutate the H5N1 bird flu virus into a strain that could be highly infectious and deadly to humans.

Global alarm as Dutch lab creates highly contagious killer flu
Rotterdam (The Netherlands), Dec.20 : A deadly strain of bird flu with the potential to infect and kill millions of people has been created in a laboratory by Dutch scientists who now want to publish full details of how they did it.

UN warns about bird flu fear as mutant strain hits China and Vietnam
The United Nations has warned China and Vietnam against the spread of avian flu that can put human life in great danger.

Zoo authorities in Jharkhand prohibit visitors from going near enclosures
Authorities in Ranchi zoo prohibited the visitors from going near the enclosures after bird flu alert was sounded in the state.

Bird flu outbreak confirmed in West Bengal's Nadia District
Bird flu has been confirmed in poultry samples collected from two villages of Tehatta I block in West Bengal's Nadia District.

Rampant culling of chickens on in Assam following bird flu outbreak
The outbreak of bird flu in Assam's Dhubri district has forced officials to go on alert to spread of the infection among the people of the area.

Man-made deadly flu virus could wipe out humanity
A group of scientists has caused a storm of controversy after creating a man-made virus that could potentially wipe out humanity if it ever escaped the laboratory where it was made.

Soon, single vaccine to give lifelong protection against all flu strains
A single flu vaccine that would protect against all strains of the virus for life may be coming soon, which could make annual flu jabs that cost the NHS around 100m pound per year a history.

Cosi, Inc. Reports Second Quarter Sales
Così, Inc. (NASDAQ: COSI), the premium convenience restaurant company, today reported that system-wide comparable restaurant sales for the 2011 second quarter as measured for restaurants in operation for more than 15 months decreased by 0.2% when compared to the second quarter of 2010

Cosi, Inc. Reports 2011 First Quarter Results
Così, Inc. (NASDAQ: COSI), the premiumconvenience restaurant company, today reported a net loss for the firstquarter ended March 28, 2011 of $(2,140,000), or $(0.04) per basic anddiluted common share, compared with a net loss of $(3,054,000), or $(0.06)per basic and diluted common share, for the 2010 first quarter.

Comment on this story

Share